Economics

This channel highlights factors that impact hospital and healthcare economics and revenue. This includes news on healthcare policies, reimbursement, marketing, business plans, mergers and acquisitions, supply chain, salaries, staffing, and the implementation of a cost-effective environment for patients and providers.

RSS icon

Cardiologists fear new regulations will cause a medical device shortage in Europe

Diagnostic catheters, ablation catheters and stents are just some of the solutions cardiologists are now struggling to obtain.

High copays keep many heart failure patients from filling needed prescriptions

Researchers examined data from more than 900 patients, presenting their findings in the Journal of the American Heart Association.

healthcare value value-based care money dollar

FDA approves world’s most expensive drug, a hemophilia B treatment expected to cost $3.5M

The single-dose gene therapy can help patients reduce their risk of bleeding events and discontinue factor IX prophylaxis therapy.

Elon Musk and Eli Lilly: How a fake tweet caused chaos and reignited the debate over insulin prices

Updated Twitter policies have helped online pranksters cause mischief in recent days, including one specific user who impersonated Eli Lilly and Company and posted that insulin was now free. Lilly's CEO has now commented on the fake tweet read 'round the world—and what it could mean for the company going forward. 

Pulmonary hypertension (PAH) is usually treated with medication, but the more a patient has to pay for medications, the less likely they are to take them and become noncompliant. This was the finding of a new study showing how copayments may be a barrier to patients taking prostanoids and combination therapy for PAH.

Higher copayments lowered adherence for pulmonary artery hypertension medications 

The more a patient has to pay for medications, the less likely they are to take them. This was the finding of a new study showing how copayments may be a barrier to drugs to treat pulmonary arterial hypertension.

U.S. Food and Drug Administration Commissioner Robert Califf, MD, who is a cardiologist, spoke at the opening session of the American Heart Association (AHA) last week about the need for doctors and health systems to step up to address two major problems - misinformation and health disparities.

FDA Commissioner Robert Califf calls on cardiology to address health inequities and combat misinformation

FDA Commissioner Robert Califf, MD, who is a cardiologist, spoke at the opening session of the American Heart Association about the need to step up and address two major problems in the American healthcare system. 

ACC President Ed Fry, MD, an interventional and general cardiologist at Ascension St. Vincent Hospital in Indianapolis, Indiana, and chair of the Ascension National Cardiovascular Service Line, says Medicare cuts for 2023 are a tipping point that need to be a call to action across medicine. #AHA22 #ACC

VIDEO: ACC president says Medicare cuts should be a call to action across healthcare

American College of Cardiology President Edward Fry, MD, spoke about recent Medicare cuts at the American Heart Association Scientific Sessions conference in Chicago. 

Thumbnail

Neuroimaging recedes behind other cost compilers in stroke care

Contrary to older research that showed neuroimaging emerging as the single most dominating cost contributor in ischemic stroke care for older Americans, a new study shows treatment and other line items account for bigger slices of the bill.

Displaying 313 - 320 of 1699

Around the web

Health Imaging
Use of AI opportunistic screening in CT for cardiovascular disease

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.

Health Imaging
New imaging protocols proposed to curb rise of cardiovascular infections

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.